Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Radiotherapy × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 9 Solid Tumor, Adult 3 Retinoblastoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solitary Fibrous Tumor, Pleural 2 Solid Tumor 2 Solid Tumors 1 Sarcoma 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Postoperative Complications 1 Neuroblastoma 1 Metastatic Solid Tumors of Metastatic Disease 1 Head and Neck Carcinoma of Unknown Primary 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Bone Metastases 1 Advanced Solid Tumors 1

Interventions

Injections 21 Carboplatin 16 Docetaxel 13 Paclitaxel 10 Bevacizumab 10 pembrolizumab 9 Fluorouracil 7 Cisplatin 7 durvalumab 6 Nivolumab 6 Leucovorin 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Pemetrexed 5 talazoparib 4 olaparib 4 Panobinostat 4 Oxaliplatin 4 Itraconazole 4 Irinotecan 4 Capecitabine 4 zimberelimab 3 toripalimab 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3 Sorafenib 3 ST 1481 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06368960 2024-04-16

BM201-1001

InnoBM Pharmaceuticals Co., Ltd.

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡